CP and infection: Neutralizing monoclonal antibodies doses have 15 to 20 times the amount of specific antibody for spike protein, compared to CP equivalents (9, 10), and they also prevent infection (10, 11), reduce outpatient progression to hospitalization (12), and have a smaller impact on already hospitalized patients (13, –, 15).